Trump psychedelic therapy order spurs drugmakers’ stock surge
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
An order related to psychedelic therapy from Trump has reportedly been issued, leading to an increase in the stock value of certain drugmakers. This development has resulted in a surge in the shares of companies involved in the production of psychedelic drugs. The order's impact on the stock market is being closely monitored, with shares of relevant companies experiencing a lift.